25
Dennis J. Ahnen MD, AGAF, FACG Colorectal Cancer The Preventable Killer Relevant Conflicts of Interest Co-Investigator (past)- CRC screening trial for stool DNA test Co-Investigator (current)- CRC Screening trial of colonoscopy vs FIT Co-Author- Modeling studies commissioned by ACS for current guidelines Dennis J. Ahnen, MD, AGAF, FACG Director Genetics Clinic, Gastroenterology of the Rockies Professor Emeritus, University of Colorado School of Medicine

Colorectal Cancer The Preventable Killer...Dennis J. Ahnen MD, AGAF, FACGDennis J. Ahnen MD, AGAF, FACG Colorectal Cancer The Preventable Killer Relevant Conflicts of Interest Co-Investigator

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

  • Dennis J. Ahnen MD, AGAF, FACGDennis J. Ahnen MD, AGAF, FACG

    Colorectal CancerThe Preventable Killer

    Relevant Conflicts of InterestCo-Investigator (past)- CRC screening trial for stool DNA testCo-Investigator (current)- CRC Screening trial of colonoscopy vs FITCo-Author- Modeling studies commissioned by ACS for current guidelines

    Dennis J. Ahnen, MD, AGAF, FACGDirector Genetics Clinic, Gastroenterology of the Rockies

    Professor Emeritus, University of Colorado School of Medicine

  • Colorectal Cancer is the result of a sequence of biologic events; It is

    • Common• Lethal• Preventable

    Dennis J. Ahnen MD, AGAF, FACGDennis J. Ahnen MD, AGAF, FACG

    Colorectal CancerThe Preventable Killer

  • What is Colorectal Cancer?

  • Normalepithelium

    Abnormalepithelium

    Smalladenoma

    Largeadenoma

    Coloncarcinoma

    10-15 Years

    The Adenoma Carcinoma Sequence

  • Lung

    CRC

    145,600

    Other

    Prostate

    Breast

    United StatesNew Cases- 1,762,450

    CRC is Common

    Breast

    LungProstate

    CRC

    212

    WyomingNew Cases- 2580

    Other

  • Siegel R: Source:-SEER 9 delay-adjusted rates, 1975-2012; 2-yr moving average.

    0

    2

    4

    6

    8

    10

    12

    14

    1975

    -76

    1981

    -82

    1987

    -88

    1993

    -94

    1999

    -00

    2005

    -06

    2011

    -12

    Men

    Women

    51% since 1994

    0

    50

    100

    150

    200

    250

    300

    1975

    -76

    1981

    -82

    1987

    -88

    1993

    -94

    1999

    -00

    2005

    -06

    2011

    -12

    Inci

    denc

    e ra

    te p

    er 1

    00,0

    00

    Men

    Women

    Ages 50+ Ages 20-49

    40% since 1987

    CRC Incidence Over TimeThe Good and Bad

    Inci

    denc

    e/10

    0,00

    0

    Inci

    denc

    e/10

    0,00

    0

    ≈15,000 new YO-CRCs

    1975 1985 1995 2005 2015 1975 1985 1995 2005 2015

    PresenterPresentation NotesNote difference in axis

  • CRC Risk Factors Demographic

    • Country of origin• Age• Sex• Race/Ethnicity• SES• Family History

  • Fold

    Ris

    k

    Lifetime Risk 5%

    Screening Intensity

    Family History and CRC Risk

    Chart1

    1 FDR/Ca

    1 FDR < 50

    2 FDR/Ca

    >2 FDR/Ca

    Lynch

    Relative risk

    2.5

    4

    3.5

    8

    9.5

    Sheet1

    1 FDR/Ca1 FDR < 502 FDR/Ca>2 FDR/CaLynch

    Relative risk2.543.589.5

  • CRC Risk Factors Demographic

    • Country of origin• Age• Sex• Race/Ethnicity• SES• Family History

    Lifestyle• Obesity• Low Physical Activity• Smoking• Alcohol

    Diet• High Red/Processed Meat• Low Fiber Containing foods

    •Fruits and Vegetables

    Failure to Get Screened

  • Lung

    CRC

    50,260

    BreastProstate

    Other

    Pancreas

    United StatesDeaths- 606,880

    CRC is LethalWyoming

    Deaths- 938

    LungCRC

    91

    BreastProstate

    Other

    Pancreas

  • CRC Staging

    5 year survival

    80-95%70-75%

    30-65%

  • CRC is Preventable- Modifable Risk FactorsDemographic

    • Country of origin• Age• Sex• Race/Ethnicity• SES• Family History

    Lifestyle• Obesity• Low Physical Activity• Smoking• Alcohol

    Diet• High Red/Processed Meat• Low Fiber Containing foods

    • Low Fruit and Vegetable

    Modifiable

  • xxCRC Prevention

  • Risk Factors Demographic

    • Country of origin• Age• Sex• Race/Ethnicity• SES• Family History

    Lifestyle• Obesity• Low Physical Activity• Smoking• Alcohol

    Diet• High Red/Processed Meat• Low Fiber Containing foods

    • Low Fruit and Vegetable

    Protective Factors• Aspirin for selected groups• Screening

  • CRC Screening- Risk Groups• Average risk

    • No personal or FH of colonic neoplasia or IBD • Start CRC screening at age 45/50, stop at age 75-85• Options for screening

    • hsFOBT/FIT- annually • FIT/DNA- every 3 years• Flexible Sigmoidoscopy- every 5 years• CT Colonography- every 5 years• Colonoscopy- every 10 years

    • If done- CRC cases and deaths by 60-80%

  • Current Screening Guidelines• USPSTF 2016- “recommends CRC

    screening starting at age 50 years and continuing until age 75…. multiple screening strategies to choose from” (A recommendation) Individualize screening age 76-85

    • ACS 2017- Repeated modeling studies using current incidence and mortality rates for the young. 0

    2

    4

    6

    8

    10

    12

    14

    1975

    1981

    1987

    1993

    1999

    2005

    2011

    Men

    Women

    Ages 20-49

    Inci

    denc

    e/10

    0,00

    0

    1975 1985 1995 2005 2015

    • Conclusion- starting at age 45 led to a 4-8% decrease in number of new CRCs, and an 8-11% decrease in CRC deaths with a 12-17% increase in the number of colonoscopies needed, compared to starting at age 50.

  • Screening at 45 is Cost-Effective• Modeling cost-effectiveness of starting CRC

    screening at 45 vs 50• Threshold for acceptable cost- $100,000/QALY gained

    • If colonoscopy used throughout• $33,900/QALY gained

    • If FIT used throughout• $7,700/QAYL gained

    • If FIT from 45-49 then colonoscopy• $2,500/QALY gained- a bargain

    Ladabaum et al Gastroenterology 2019

  • Current Screening Guidelines• USPSTF 2016- “recommends CRC screening starting at

    age 50 years and continuing until age 75…. multiple screening strategies to choose from” Individualize screening age 76-85

    • ACS 2018- “recommends that adults aged 45 years and older with average risk of colorectal cancer undergo regular screening” and continuing until age 75 with any of multiple screening strategies Individualize screening age 76-85

    • State legislatures decide which guidelines insurers in their state must follow- Colorado is currently a USPSTF state

  • CRC Screening- Risk Groups• Increased risk- FDRs of patients with CRC or

    Advanced Adenomas• Start at age 40 or earlier depending on # and age of

    CRCs in family, colonoscopy is preferred • Hereditary Syndromes

    • Start much earlier (12-25), annual colonoscopy

  • Family History of CRC Increases Risk

    Fuchs et al NEJM 1994

    PresenterPresentation NotesFamily history is a risk factor for colorectal cancer, and cancer tends to occur at an earlier age. On average, patients with a family member with a history of colorectal cancer develop cancer approximately 10 years earlier.

  • Familial and Hereditary CRC

    Burt RW et al. Prevention and Early Detection of CRC, 1996

    Sporadic(≈ 70%)

    Familial (≈ 25%)

    Lynch Syndrome (2-3%) (HNPCC)

    Familial Adenomatous Polyposis (

  • Lynch Syndrome• Autosomal Dominant ≈ 1/300 – 3% of CRCs-• High CRC risk- up to 50%• Early onset- 44 yrs• Proximal location- 65%• Other cancers (Uterus, Ovary)• Under-recognized (

  • Familial Adenomatous Polyposis

    Rare- 1/7,000 to 1/22,000 Autosomal Dominant High CRC risk ≈100% Easily recognized Genetic testing or

    screening around age 12 Surveillance annually Attenuated FAP is

    different

  • Colorectal Cancer- The Preventable Killer• Sequential progression from polyp to cancer• Common-

    • 4th most common cancer in US and CO• Decreasing but increasing in the young

    • Lethal• 2nd most common cause of cancer death in US/CO• Strongly dependent on stage at diagnosis

    • Preventable• Prudent lifestyle changes• Screening is most effective prevention as well as early detection

    strategy• Familial and Hereditary CRC require special attention

  • Slide Number 1Slide Number 2Slide Number 3Slide Number 4CRC is CommonCRC Incidence Over Time�The Good and BadCRC Risk Factors �Family History and CRC RiskCRC Risk Factors �Slide Number 10CRC StagingCRC is Preventable- Modifable Risk Factors�CRC Prevention�Risk Factors �Slide Number 15Slide Number 16Slide Number 17Slide Number 18Slide Number 19Slide Number 20Slide Number 21Lynch SyndromeFamilial Adenomatous PolyposisSlide Number 24Slide Number 25